α7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia

被引：46
|
作者：
Ishikawa, Masatomo [1 ]
Hashimoto, Kenji [1 ]
机构：
[1] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan
来源：
CURRENT PHARMACEUTICAL DESIGN | 2011年 / 17卷 / 02期
关键词：
alpha 7 nicotinic acetylcholine receptors; schizophrenia; smoking; nicotine; P50 auditory evoked potential suppression; agonists; allosteric modulators; VITRO PHARMACOLOGICAL CHARACTERIZATION; POSITIVE ALLOSTERIC MODULATOR; INDUCED COGNITIVE DEFICITS; REPEATED AUDITORY-STIMULI; IN-VIVO CHARACTERIZATION; MIDBRAIN DOPAMINE AREAS; CIGARETTE-SMOKING; P50; SUPPRESSION; PARTIAL AGONIST; DBA/2; MICE;
D O I：
10.2174/138161211795049561
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Accumulating evidence suggests that the alpha 7 subtype of nicotinic acetylcholine receptors (nAChRs) plays a role in the pathophysiology of schizophrenia. Deficits in auditory P50 evoked potential suppression in patients with schizophrenia are associated with decreased density of alpha 7 nAChRs in the brain. Some agonists (e. g., DMXB-A and tropisetron) at alpha 7 nAChRs can improve P50 deficits in patients with schizophrenia. Together, these findings indicate that alpha 7 nAChRs are a potential therapeutic target for schizophrenia. Currently, a number of agonists and allosteric modulators at alpha 7 nAChRs are under development as potential therapeutic drugs. In this article, we review recent topics on alpha 7 nAChR agonists and alpha 7 nAChR allosteric modulators as therapeutic drugs for schizophrenia.
引用
收藏
页码：121 / 129
页数：9
相关论文
共 50 条
  • [41] Association Study of Polymorphisms in Neuronal Nicotinic Acetylcholine Receptor Subunit Genes With Schizophrenia in the Han Chinese Population
    Li, Yuan-yuan
    Geng, Rui-jie
    Yu, Shun-ying
    Li, Guan-jun
    Wang, Zhou-ye
    Li, Hua-fang
    PSYCHIATRY INVESTIGATION, 2021, 18 (10) : 943 - 948
  • [42] The role of the α7 nicotinic receptor in cognitive processing of persons with schizophrenia
    AhnAllen, Christopher G.
    CURRENT OPINION IN PSYCHIATRY, 2012, 25 (02) : 103 - 108
  • [43] Lower β2*-Nicotinic Acetylcholine Receptor Availability in Smokers With Schizophrenia
    D'Souza, Deepak Cyril
    Esterlis, Irina
    Carbuto, Michelle
    Krasenics, Maegan
    Seibyl, John
    Bois, Frederic
    Pittman, Brian
    Ranganathan, Mohini
    Cosgrove, Kelly
    Staley, Julie
    AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (03) : 326 - 334
  • [44] Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia
    Wallace, Tanya L.
    Bertrand, Daniel
    NICOTINE USE IN MENTAL ILLNESS AND NEUROLOGICAL DISORDERS, 2015, 124 : 79 - 111
  • [45] Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
    Bacher, Ingrid
    Wu, Becky
    Shytle, Douglas R.
    George, Tony P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (16) : 2709 - 2721
  • [46] B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor
    Post-Munson, Debra J.
    Pieschl, Rick L.
    Molski, Thaddeus F.
    Graef, John D.
    Hendricson, Adam W.
    Knox, Ronald J.
    McDonald, Ivar M.
    Olson, Richard E.
    Macor, John E.
    Weed, Michael R.
    Bristow, Linda J.
    Kiss, Laszlo
    Ahlijanian, Michael K.
    Herrington, James
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 799 : 16 - 25
  • [47] Evidence of Association between Smoking and α7 Nicotinic Receptor Subunit Gene in Schizophrenia Patients
    Vincenzo De Luca
    Albert HC Wong
    Daniel J Muller
    Gregory WH Wong
    Rachel F Tyndale
    James L Kennedy
    Neuropsychopharmacology, 2004, 29 : 1522 - 1526
  • [48] Evidence of association between smoking and α7 nicotinic receptor subunit gene in schizophrenia patients
    De Luca, V
    Wong, AHC
    Muller, DJ
    Wong, GWH
    Tyndale, RF
    Kennedy, JL
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (08) : 1522 - 1526
  • [49] Evidence for a role of nicotinic acetylcholine receptors in schizophrenia
    Adams, Catherine E.
    Stevens, Karen E.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4755 - 4772
  • [50] Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder
    Thomsen, Morten S.
    Weyn, Annelies
    Mikkelsen, Jens D.
    BIPOLAR DISORDERS, 2011, 13 (7-8) : 701 - 707
12345